LLY Insider Trading

Insider Ownership Percentage: 0.13%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,541,282.00

Eli Lilly and Company Insider Trading History Chart

This chart shows the insider buying and selling history at Eli Lilly and Company by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$20B-$10B$0$10B$20BTotal Insider BuyingTotal Insider Selling

Eli Lilly and Company Share Price & Price History

Current Price: $793.34
Price Change: Price Increase of +2.69 (0.34%)
As of 07/11/2025 04:59 PM ET

This chart shows the closing price history over time for LLY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
AugSepOctNovDecJanFebMarAprMayJunJul$793.34Closing price on 07/12/25:

SEC Filings (Institutional Ownership Changes) for Eli Lilly and Company (NYSE:LLY)

82.53% of Eli Lilly and Company stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at LLY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.06Bbought$88MsoldQ3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3-$50B$0$50BTotal InflowsTotal Outflows
Eli Lilly and Company logo
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Read More on Eli Lilly and Company

Today's Range

Now: $793.34
Low: $777.20
High: $795.73

50 Day Range

MA: $766.39
Low: $713.99
High: $821.66

52 Week Range

Now: $793.34
Low: $677.09
High: $972.53

Volume

2,851,585 shs

Average Volume

3,675,715 shs

Market Capitalization

$751.88 billion

P/E Ratio

64.55

Dividend Yield

0.76%

Beta

0.4

Who are the company insiders with the largest holdings of Eli Lilly and Company?

Eli Lilly and Company's top insider shareholders include:
  1. Lilly Endowment Inc (Major Shareholder)
  2. Johna Norton (EVP)
  3. Alonzo Weems (EVP)
  4. Donald A Zakrowski (CAO)
Learn More about top insider investors at Eli Lilly and Company.

Who are the major institutional investors of Eli Lilly and Company?

Eli Lilly and Company's top institutional shareholders include:
  1. Assenagon Asset Management S.A. — 0.16%
  2. Swedbank AB — 0.14%
  3. Sapient Capital LLC — 0.13%
  4. Goelzer Investment Management Inc. — 0.06%
  5. Kingstone Capital Partners Texas LLC — 0.03%
  6. Mn Services Vermogensbeheer B.V. — 0.03%
Learn More about top institutional investors of Eli Lilly and Company stock.

Which major investors are selling Eli Lilly and Company stock?

During the last quarter, LLY stock was sold by these institutional investors:
  1. E. Ohman J or Asset Management AB
  2. InvesTrust
  3. Weatherly Asset Management L. P.
  4. BDF Gestion
  5. UMB Bank n.a.
  6. Quintet Private Bank Europe S.A.
  7. Tompkins Financial Corp
  8. Pallas Capital Advisors LLC

Which major investors are buying Eli Lilly and Company stock?

In the last quarter, LLY stock was purchased by institutional investors including:
  1. Assenagon Asset Management S.A.
  2. Kingstone Capital Partners Texas LLC
  3. Swedbank AB
  4. Wealth Enhancement Advisory Services LLC
  5. Czech National Bank
  6. Sapient Capital LLC
  7. Sarasin & Partners LLP
  8. Family Legacy Financial Solutions LLC